Bioanalytical Systems (BASI) 2.06 $BASI
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Bioanalytical Systems' (BASI) CEO Jacqueline Lemke on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:32PM CST
BASI: 2.06 (+0.18)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:45AM CST
CERU: 6.62 (-0.06), TBIO: 2.91 (+0.01), FXEN: 1.99 (+0.10), TRIP: 84.81 (+2.41), STMP: 56.92 (-0.24), ZEN: 25.38 (+1.02), OWW: 11.68 (-0.04), PME: 2.42 (-0.07), OESX: 4.15 (-0.01), GENE: 8.04 (+1.90), BG: 82.22 (+1.78), ARCI: 2.53 (-0.01), NTWK: 5.14 (-0.11), BASI: 2.06 (+0.18), EXPE: 89.49 (-0.08), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), LTRPA: 31.12 (+0.77), DWSN: 6.89 (-0.42), ZU: 14.22 (-0.30)
Bioanalytical Systems reports FQ1 results
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:06AM CST
BASI: 2.06 (+0.18)
BASi Reports First Quarter Results
Business Wire - Thu Feb 12, 8:01AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter of fiscal 2015.
BASI: 2.06 (+0.18)
BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services
Business Wire - Wed Feb 11, 10:39AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the addition of Srini Jayaraman,Ph.D. as Principal Investigator Discovery, and Braden M. Kemmerling D.V.M. as Attending Veterinarian Preclinical Services to the scientific team.
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release First Quarter Fiscal 2015 Results on Thursday, February 12, 2015; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Wed Feb 04, 9:05AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will report financial results for the first quarter of fiscal 2015 ended December 31, 2014, prior to the market opening on Thursday, February 12, 2015. A conference call has been scheduled at 11:00 a.m. Eastern Standard Time (EST) to discuss the results. To participate in the call, dial 800-591-6942, participant passcode 59711082.
BASI: 2.06 (+0.18)
Bioanalytical Systems, Inc. to Present at the 11th Annual Noble Financial Capital Markets Equity Conference Tuesday, January 20, 2015 at 11:00 a.m. EST
Business Wire - Tue Jan 06, 9:53AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that Jacqueline Lemke, President and CEO, will present at the Noble Financial Capital Markets Eleventh Annual Equity Conference on Tuesday, January 20, 2015 at 11:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida.
BASI: 2.06 (+0.18)
Bioanalytical Systems Q4 Loss Widens, Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:00AM CST
Bioanalytical Systems, Inc. (BASI) reported fourth quarter fiscal 2014 loss of 2 cents per share, which doubled from the year-ago loss of a penny
FLDM: 37.93 (-0.47), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), ELMD: 2.35 (-0.15)
Bioanalytical Systems ups revenues 16% in FQ4
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 8:35AM CST
BASI: 2.06 (+0.18)
Bioanalytical Systems EPS of -$0.02
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 8:05AM CST
BASI: 2.06 (+0.18)
BASi Reports Fourth Quarter and Full Year 2014 Results
Business Wire - Mon Dec 22, 8:03AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the fourth quarter and the full fiscal year ended September 30, 2014.
BASI: 2.06 (+0.18)
Bioanalytical Systems reports December 22
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 7:47AM CST
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Monday December 22, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Tue Dec 16, 4:18PM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will now report fourth quarter and full year 2014 financial results prior to the market opening on Monday, December 22, 2014. A conference call is scheduled at 11:00 a.m. Eastern Standard Time (EST) on the same day.
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Fri Dec 12, 3:25PM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 877-415-3179, participant passcode 30119869.
BASI: 2.06 (+0.18)
BASi's Culex(R) L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
Business Wire - Tue Dec 02, 9:56AM CST
For nearly 15 years, the Culex(R) Automated Blood Sampling systems have allowed researchers to collect better data from non-stressed subjects. The cutting edge system saves time, saves money and saves lives by streamlining the drug discovery process and answering complicated questions at very early stages in research. Now, Bioanalytical Systems, Inc. (NASDAQ:BASI) has expanded that offering to a growing segment of drug discovery research utilizing swine as a research model.
BASI: 2.06 (+0.18)
Bioanalytical Systems (BASI) Upgraded From Sell to Hold
at The Street - Tue Nov 11, 8:08AM CST
Bioanalytical Systems (BASI) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
BASI: 2.06 (+0.18)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 16.82 (+0.17), HBNK: 21.40 (+0.25), BRDR: 6.15 (+0.04), SAPE: 24.98 (-0.02), TAIT: 1.03 (+0.03), BASI: 2.06 (+0.18), GERN: 3.03 (unch), NYMX: 0.36 (-0.02), MTEX: 23.89 (+0.69), CKEC: 29.96 (+0.89), ALQA: 6.14 (+0.09)
BASi Names Connie Dougherty Vice President Business Development
Business Wire - Tue Sep 16, 2:02PM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Connie Dougherty as Vice President of Business Development reporting to BASi President and Chief Executive Officer Jacqueline Lemke. She will provide leadership to drive BASi's growth initiatives and efforts to expand the Company's footprint.
BASI: 2.06 (+0.18)
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Bioanalytical Systems' (BASI) CEO Jacqueline Lemke on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:32PM CST
BASI: 2.06 (+0.18)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:45AM CST
CERU: 6.62 (-0.06), TBIO: 2.91 (+0.01), FXEN: 1.99 (+0.10), TRIP: 84.81 (+2.41), STMP: 56.92 (-0.24), ZEN: 25.38 (+1.02), OWW: 11.68 (-0.04), PME: 2.42 (-0.07), OESX: 4.15 (-0.01), GENE: 8.04 (+1.90), BG: 82.22 (+1.78), ARCI: 2.53 (-0.01), NTWK: 5.14 (-0.11), BASI: 2.06 (+0.18), EXPE: 89.49 (-0.08), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), LTRPA: 31.12 (+0.77), DWSN: 6.89 (-0.42), ZU: 14.22 (-0.30)
Bioanalytical Systems reports FQ1 results
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:06AM CST
BASI: 2.06 (+0.18)
BASi Reports First Quarter Results
Business Wire - Thu Feb 12, 8:01AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter of fiscal 2015.
BASI: 2.06 (+0.18)
BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services
Business Wire - Wed Feb 11, 10:39AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the addition of Srini Jayaraman,Ph.D. as Principal Investigator Discovery, and Braden M. Kemmerling D.V.M. as Attending Veterinarian Preclinical Services to the scientific team.
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release First Quarter Fiscal 2015 Results on Thursday, February 12, 2015; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Wed Feb 04, 9:05AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will report financial results for the first quarter of fiscal 2015 ended December 31, 2014, prior to the market opening on Thursday, February 12, 2015. A conference call has been scheduled at 11:00 a.m. Eastern Standard Time (EST) to discuss the results. To participate in the call, dial 800-591-6942, participant passcode 59711082.
BASI: 2.06 (+0.18)
Bioanalytical Systems, Inc. to Present at the 11th Annual Noble Financial Capital Markets Equity Conference Tuesday, January 20, 2015 at 11:00 a.m. EST
Business Wire - Tue Jan 06, 9:53AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that Jacqueline Lemke, President and CEO, will present at the Noble Financial Capital Markets Eleventh Annual Equity Conference on Tuesday, January 20, 2015 at 11:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida.
BASI: 2.06 (+0.18)
Bioanalytical Systems Q4 Loss Widens, Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:00AM CST
Bioanalytical Systems, Inc. (BASI) reported fourth quarter fiscal 2014 loss of 2 cents per share, which doubled from the year-ago loss of a penny
FLDM: 37.93 (-0.47), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), ELMD: 2.35 (-0.15)
Bioanalytical Systems ups revenues 16% in FQ4
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 8:35AM CST
BASI: 2.06 (+0.18)
Bioanalytical Systems EPS of -$0.02
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 8:05AM CST
BASI: 2.06 (+0.18)
BASi Reports Fourth Quarter and Full Year 2014 Results
Business Wire - Mon Dec 22, 8:03AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the fourth quarter and the full fiscal year ended September 30, 2014.
BASI: 2.06 (+0.18)
Bioanalytical Systems reports December 22
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 7:47AM CST
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Monday December 22, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Tue Dec 16, 4:18PM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will now report fourth quarter and full year 2014 financial results prior to the market opening on Monday, December 22, 2014. A conference call is scheduled at 11:00 a.m. Eastern Standard Time (EST) on the same day.
BASI: 2.06 (+0.18)
Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Fri Dec 12, 3:25PM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 877-415-3179, participant passcode 30119869.
BASI: 2.06 (+0.18)
BASi's Culex(R) L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
Business Wire - Tue Dec 02, 9:56AM CST
For nearly 15 years, the Culex(R) Automated Blood Sampling systems have allowed researchers to collect better data from non-stressed subjects. The cutting edge system saves time, saves money and saves lives by streamlining the drug discovery process and answering complicated questions at very early stages in research. Now, Bioanalytical Systems, Inc. (NASDAQ:BASI) has expanded that offering to a growing segment of drug discovery research utilizing swine as a research model.
BASI: 2.06 (+0.18)
Bioanalytical Systems (BASI) Upgraded From Sell to Hold
at The Street - Tue Nov 11, 8:08AM CST
Bioanalytical Systems (BASI) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
BASI: 2.06 (+0.18)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 16.82 (+0.17), HBNK: 21.40 (+0.25), BRDR: 6.15 (+0.04), SAPE: 24.98 (-0.02), TAIT: 1.03 (+0.03), BASI: 2.06 (+0.18), GERN: 3.03 (unch), NYMX: 0.36 (-0.02), MTEX: 23.89 (+0.69), CKEC: 29.96 (+0.89), ALQA: 6.14 (+0.09)
BASi Names Connie Dougherty Vice President Business Development
Business Wire - Tue Sep 16, 2:02PM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Connie Dougherty as Vice President of Business Development reporting to BASi President and Chief Executive Officer Jacqueline Lemke. She will provide leadership to drive BASi's growth initiatives and efforts to expand the Company's footprint.
BASI: 2.06 (+0.18)
